Taking stock: Amyris, Solazyme, BioAmber, and Gevo spent Q1 2015 expanding market opportunities

May 14, 2015 | Analyst Insight

On May 5, 2015, Amyris announced its Q1 2015 results and noted the company ended the quarter with a positive cash flow of $1.7 million, total revenues of $7.9...

Categories	Sugar / starch feedstocks, Bio-based specialty chemical products, Bio-oil and bio-oil derivative products, Drop-in BBMC products, Fermentation, Improvement BBMC products, Intermediate chemical products, Algae
Related companies	Bayer MaterialScience, Solazyme, Amyris, Gevo, BioAmber, Bunge Limited, Fosun Pharma, Genome Compiler, Flotek Industries, Squalan Natural Health, Alaska Airlines

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978